Lyka Labs Q1 FY27 Results: Revenue Rs 42 Cr, PAT Rs 2 Cr and Key Highlights

Lyka Labs Q1 FY27 results were announced on August 10, 2026, with the pharmaceuticals company reporting a net profit (PAT) of Rs 2 crore, up 105.44% from Rs 1 crore in Q1 FY26. Revenue from operations in the Lyka Labs Q1 FY27 results rose 28.11% year on year to Rs 42 crore from Rs 33 crore in Q1 FY26. These Lyka Labs Q1 FY27 results are on a consolidated basis for the quarter ended June 30, 2026.

Click Here – Get Free Investment Predictions

Lyka Labs Q1 FY27 Financial Highlights

The table below presents the key financial metrics from the Lyka Labs Q1 FY27 results compared with the corresponding quarter of the previous year.

Metric	Q1 FY27 (Jun 2026)	Q1 FY26 (Jun 2025)	YoY Change
Revenue from Operations (Rs Cr)	Rs 42 Cr	Rs 33 Cr	+28.11%
Gross Profit (Rs Cr)	Rs 2 Cr	Rs 1 Cr	+61.16%
Net Profit / (Loss) – PAT (Rs Cr)	Rs 2 Cr	Rs 1 Cr	+105.44%

Lyka Labs Q1 FY27 Performance Analysis

Use the Univest Screener to Track Live Fundamentals of Indian Stocks

The Lyka Labs Q1 FY27 results show revenue growth of 28.11% year on year to Rs 42 crore. Gross profit improved to Rs 2 crore from Rs 1 crore in Q1 FY26.

Net profit in the Lyka Labs Q1 FY27 results stood at Rs 2 crore, up 105.44% from Rs 1 crore in Q1 FY26. Investors tracking the Lyka Labs Q1 FY27 results should verify these figures against the official BSE and NSE filings for accuracy.

Key Business Factors in Lyka Labs Q1 FY27

1. Revenue Growth Drove Top-Line Expansion

The Lyka Labs Q1 FY27 results show revenue growing 28.11% year on year to Rs 42 crore. The improvement reflects stronger demand or expanded operations within the Pharmaceuticals segment during the June 2026 quarter.

2. Gross Profit Momentum Supported Margins

Gross profit in the Lyka Labs Q1 FY27 results improved to Rs 2 crore from Rs 1 crore in Q1 FY26, a gain of 61.16%.

3. Net Profit Improvement in Q1 FY27

The Lyka Labs Q1 FY27 results delivered a net profit (PAT) of Rs 2 crore, up 105.44% from Rs 1 crore in Q1 FY26. This profit improvement reflects the company's improving operational leverage in the Pharmaceuticals space.

Dividend Details

No dividend has been declared alongside the Lyka Labs Q1 FY27 results for the quarter ended June 2026. Investors may track any future dividend announcements via BSE India and NSE India.

Lyka Labs FY27 Outlook After Q1 Results

The Lyka Labs Q1 FY27 results set a broadly positive tone for the full financial year. Revenue growth of 28.11% and a net profit (PAT) of Rs 2 crore provide a foundation for further improvement. Investors tracking the Lyka Labs Q1 FY27 results should monitor demand conditions in the Pharmaceuticals sector, input cost movements, and any capacity or business expansion plans that could drive earnings through the remainder of FY27.

Lyka Labs Stock Performance

Download the Univest iOS App or Univest Android App to track Lyka Labs live share price and upcoming quarterly results.

Lyka Labs share price stood at Rs 68.07 on August 10, 2026, the day the Lyka Labs Q1 FY27 results were declared. Post-results, the market will assess whether the Pharmaceuticals company's financial performance justifies the current valuation. Investors should verify the latest price and fundamentals before making any decision.

Key Risks to Watch After Lyka Labs Q1 FY27 Results

1. Sector-Specific Demand Headwinds

A slowdown in the Pharmaceuticals sector could affect Lyka Labs revenue and profitability beyond what the Q1 FY27 results currently indicate.

2. Input Cost and Margin Pressure

Rising raw material or operational costs could compress gross margins and limit net profit improvement in subsequent quarters of FY27.

3. Macroeconomic and Regulatory Uncertainty

Broader macroeconomic headwinds including inflation, interest rate changes, and regulatory shifts remain key risks to the FY27 earnings outlook for Lyka Labs.

Conclusion

The Lyka Labs Q1 FY27 results report revenue of Rs 42 crore and a net profit (PAT) of Rs 2 crore, up 105.44% from Rs 1 crore in Q1 FY26. The Lyka Labs Q1 FY27 results reflect the company's operational position in the Pharmaceuticals sector for the June 2026 quarter. Investors should study the complete financials available on BSE and NSE and consult a SEBI-registered advisor before making any investment decision.

Frequently Asked Questions on Lyka Labs Q1 FY27 Results

When were the Lyka Labs Q1 FY27 results announced?

Ans. The Lyka Labs Q1 FY27 results were announced on August 10, 2026, covering the quarter ended June 30, 2026. The consolidated results were filed with BSE and NSE on the same date.

What is the PAT in the Lyka Labs Q1 FY27 results?

Ans. PAT (net profit) stood at Rs 2 crore in the June 2026 quarter, up 105.44% from Rs 1 crore in Q1 FY26.

What was the revenue in the Lyka Labs Q1 FY27 results?

Ans. Revenue for the June 2026 quarter rose 28.11% year on year to Rs 42 crore from Rs 33 crore in Q1 FY26.

Did Lyka Labs declare any dividend along with Q1 FY27 results?

Ans. No dividend has been declared with the Lyka Labs Q1 FY27 results for the June 2026 quarter. Investors may track future dividend announcements through the BSE and NSE portals.

What is the Lyka Labs outlook for FY27 after Q1 results?

Ans. The June 2026 quarter data signals a positive start to FY27 for Lyka Labs. Key factors to watch include revenue trends, margin performance, and sector developments through the rest of the financial year.

Is Lyka Labs a good investment after Q1 FY27 results?

Ans. The Q1 FY27 financial performance of Lyka Labs shows improving trends. This article is for educational purposes only and does not constitute investment advice. Please consult a SEBI-registered investment advisor before making any investment decision.